Global Transplantation Market to Reach US$ 26.6 Billion by 2028, Stimulated by Rising Prevalence of Chronic Diseases

July 03, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Transplantation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global transplantation market size reached US$ 14.4 Billion in 2022. Transplantation refers to the surgical procedure of transferring organs, tissues, or cells from the donor to the recipient in order to replace damaged or malfunctioning organs, restore bodily functions, and improve the recipient's quality of life. It involves the removal of a healthy organ from a deceased or living donor, which is then transplanted into a recipient who needs that particular organ. It acts as a critical medical intervention for individuals suffering from end-stage organ failure, severe injuries, or certain genetic disorders. Common organs that can be transplanted include the heart, liver, kidneys, lungs, and pancreas. The success of transplantation depends on various factors, including compatibility between the donor and recipient, availability of suitable organs or tissues, and post-transplant care to prevent rejection.

Global Transplantation Market Trends:

The market is majorly driven by the rising incidences of chronic diseases, such as end-stage renal disease, liver cirrhosis, heart failure, and lung diseases. Moreover, ongoing advancements in surgical techniques, immunosuppressive medications, and organ preservation methods have significantly improved transplantation success rates, thus contributing to the growth of the market. Besides this, various governments, healthcare organizations, and advocacy groups are actively promoting organ donation and transplantation through awareness campaigns, policy reforms, and infrastructure development, which is providing a boost to the market. In line with this, the growing establishment of international guidelines, standards, and best practices for transplantation are also impacting the market favorably. Apart from this, continual research in tissue engineering, regenerative medicine, and stem cell therapy and the development of bioartificial organs, xenotransplantation, and advancements in immunology and genomics are significantly supporting the market demand. The market is further driven by the development of robust infrastructure, including transplant centers, organ procurement organizations, and transplant networks that help coordinate organ allocation, organ transportation, and post-transplant care. Looking forward, the market value is projected to reach US$ 26.6 Billion by 2028, expanding at a CAGR of 9.6% during 2023-2028.      

Market Summary:

  • Based on the product, the market has been segmented into tissue products, immunosuppressive drugs, and preservation solution. Currently, tissue products represents the largest market segment.
  • On the basis of the application, the market has been divided into organ and tissue transplantation. Among these, tissue transplantation exhibits a clear dominance in the market.
  • Based on the end user insights, the market has been classified into hospitals, transplantation centers, and others. Among these, hospitals exhibits a clear dominance in the market.
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. Among these, North America holds the leading position in the market.
  • The competitive landscape of the market has also been examined, with some of the key players being 21st Century Medicine, AbbVie Inc., Arthrex Inc., Astellas Pharma Inc., BioLife Solutions Inc., CareDx Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., TransMedics Inc. and Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation).

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Products Covered Tissue Products, Immunosuppressive Drugs, Preservation Solution
Applications Covered Organ Transplantation, Tissue Transplantation
End Users Covered Hospitals, Transplantation Centers, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 21st Century Medicine, AbbVie Inc., Arthrex Inc., Astellas Pharma Inc., BioLife Solutions Inc., CareDx Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., TransMedics Inc., Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation), etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Transplantation Market to Reach US$ 26.6 Billion by 2028, Stimulated by Rising Prevalence of Chronic Diseases
Purchase options Year End sale

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More